Skip to main content
. 2019 Aug 8;42(4):1329–1342. doi: 10.3892/or.2019.7273

Table I.

Associations between SMC1 expression in cancer tissue and clinicopathological characteristics in patients with colorectal cancer.

SMC1 expression [N (%)]

Clinicopathological characteristic N Low expression High expression χ2 P-value
Total number 51 22 29
Sex 0.448 0.503
  Male 35 14 (63.64) 21 (72.41)
  Female 16 8 (36.36) 8 (27.59)
Age (years) 0.015 0.903
  <65 25 11 (50.00) 14 (48.28)
  ≥65 26 11 (50.00) 15 (51.72)
Location 0.019 0.889
  Rectal cancer 18 8 (36.36) 10 (34.48)
  Colon cancer 33 14 (63.64) 19 (65.52)
Cell differentiation 3.960 0.138
  Well   5 2 (9.09) 3 (10.34)
  Moderate 20 12 (54.55) 8 (27.59)
  Poor 26 8 (36.36) 18 (62.07)
TNM 7.322 0.007b
  I/II 26 16 (72.73) 10 (34.48)
  III/IV 25 6 (27.27) 19 (65.52)
Primary tumor size 4.469 0.035a
  T1-2 23 14 (63.64) 9 (31.03)
  T3-4 28 8 (36.36) 20 (68.97)
Lymph node metastasis 5.685 0.017a
  N0 25 15 (68.18) 10 (34.48)
  N1-2 26 7 (31.82) 19 (65.52)
Vascular invasion 0.292 0.589
  No 30 12 (54.55) 18 (62.07)
  Yes 21 10 (45.45) 11 (37.93)
a

P<0.05

b

P<0.01. SMC1, structural maintenance of chromosomes 1.